~10 spots leftby Apr 2026

Controlled Diets for Dietary Biomarker Identification in Healthy Adults

(P1-SDBDC Trial)

JW
ML
Overseen byMarian L. Neuhouser
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Marian Neuhouser
Must not be taking: Diuretics, Steroids, Opiates, others
Disqualifiers: Gastrointestinal disorders, Cancer, Pregnancy, others
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial involves healthy adults eating specific foods like beef, beans, and eggs to help researchers find unique markers in their blood and urine. These markers will help scientists accurately measure dietary intake.

Will I have to stop taking my current medications?

The trial requires that participants stop taking certain medications, including diuretics, steroids, opiates, and some psychiatric and anti-lipid medications. Study staff will review your medications to determine eligibility, so you may need to stop taking some of your current medications.

What data supports the effectiveness of the treatment involving controlled feeding of beef and/or pinto beans?

Research shows that consuming dry beans, like pinto beans, may help reduce the risk of certain cancers, such as colon and breast cancer, by affecting cancer-related processes in the body. This suggests that including pinto beans in a diet could have health benefits related to cancer prevention.12345

Is it safe for humans to consume controlled diets including beef, pinto beans, eggs, and black beans?

Research indicates that beans, including pinto and black beans, are generally safe for human consumption and provide nutritional benefits like protein and fiber. However, some people may experience intestinal gas from beans, and it's important to ensure a balanced diet to maintain nutrient levels.25678

How is the controlled feeding study of beef and pinto beans unique compared to other treatments?

This treatment is unique because it uses a controlled diet to identify dietary biomarkers, which are indicators in the body that reflect food intake. Unlike other treatments that may focus on single nutrients, this study evaluates the combined effects of specific foods like beef and pinto beans, potentially offering a more comprehensive understanding of diet-related health impacts.49101112

Research Team

JW

Johanna W. Lampe, PhD, RD

Principal Investigator

Fred Hutchinson Cancer Center

ML

Marian L. Neuhouser

Principal Investigator

Fred Hutchinson Cancer Center

Eligibility Criteria

Healthy adults over 18, with a BMI of 18.5-39.9 kg/m2, who can visit the Fred Hutch campus 16 times for the study are eligible. Exclusions include those with certain gastrointestinal disorders, recent surgery or cancer treatment, substance use that they're unwilling to stop during the study, and various other health conditions and medication uses.

Exclusion Criteria

I have a history of serious gut disorders like Crohn's or celiac disease.
Pregnant or lactating
Use of illicit drugs and not willing to abstain during feeding periods
See 16 more

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Controlled Feeding Period

Participants undergo a 2-day run-in of controlled feeding followed by a 7-day feeding period for each of the three feeding periods.

9 days per feeding period
3 visits (in-person) per feeding period

Washout

A 7-day washout period between each feeding period to reset dietary intake.

7 days

Follow-up

Participants are monitored for safety and effectiveness after the feeding trials, with specimen collection for study outcomes and future studies.

4 weeks

Treatment Details

Interventions

  • Controlled feeding study of beef and/or pinto beans (Behavioural Intervention)
  • Controlled feeding study of eggs and/or black beans (Behavioural Intervention)
Trial OverviewThe trial is testing how well blood and urine biomarkers can measure diet by having participants eat controlled diets including beef/pinto beans or eggs/black beans. Researchers will analyze these biological samples to identify reliable dietary intake indicators.
Participant Groups
6Treatment groups
Experimental Treatment
Group I: 6) Black bean then egg then half black bean and half eggExperimental Treatment1 Intervention
Group II: 5) Half egg and half black bean, then black bean then eggExperimental Treatment1 Intervention
Group III: 4) Egg then half Egg and half black bean then black beanExperimental Treatment1 Intervention
Group IV: 3) Pinto Bean then Beef then half pinto bean and half beefExperimental Treatment1 Intervention
Group V: 2) Half pinto bean and half beef then pinto bean then beefExperimental Treatment1 Intervention
Group VI: 1) Beef then half beef and half pinto bean then pinto beanExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Marian Neuhouser

Lead Sponsor

Trials
2
Recruited
60+

United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)

Collaborator

Trials
2
Recruited
60+

University of Nebraska

Collaborator

Trials
563
Recruited
1,147,000+
Michael Dixon profile image

Michael Dixon

University of Nebraska

Chief Executive Officer since 2010

PhD in Molecular Biology

Dr. Makker profile image

Dr. Makker

University of Nebraska

Chief Medical Officer since 2020

MD from University of Nebraska Medical School

University of Washington

Collaborator

Trials
1,858
Recruited
2,023,000+

Dr. Timothy H. Dellit

University of Washington

Chief Executive Officer since 2023

MD from University of Washington

Dr. Anneliese Schleyer

University of Washington

Chief Medical Officer since 2023

MD, MHA

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+
Mary E. Klotman profile image

Mary E. Klotman

Duke University

Chief Executive Officer since 2017

MD from Duke University School of Medicine

Michelle McMurry-Heath profile image

Michelle McMurry-Heath

Duke University

Chief Medical Officer since 2020

MD from Duke University School of Medicine

Findings from Research

Consuming pinto beans daily for 12 weeks significantly lowered total cholesterol levels by about 8% in healthy adults and 4% in those with premetabolic syndrome, indicating a positive effect on heart health.
While bean consumption increased the production of beneficial short-chain fatty acids (SCFAs) like propionate during in vitro fermentation, it did not show clear benefits for reducing colon cancer risk, as it lowered certain other SCFAs and affected only one bacterial population.
Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans.Finley, JW., Burrell, JB., Reeves, PG.[2023]
A diet incorporating small red dry beans significantly reduced mammary cancer incidence, multiplicity, and tumor burden in a study involving female Sprague Dawley rats, indicating a potential protective effect against breast cancer.
The mechanism behind this protective effect appears to be the induction of apoptosis in tumor cells, as evidenced by changes in specific protein levels associated with cell death, suggesting that dry beans may play a role in cancer prevention without relying on isoflavones.
Mechanisms associated with dose-dependent inhibition of rat mammary carcinogenesis by dry bean (Phaseolus vulgaris, L.).Thompson, MD., Thompson, HJ., Brick, MA., et al.[2008]
In a randomized crossover trial involving 64 men, a legume-enriched, low-glycemic index diet significantly improved inflammation markers (C-reactive protein and soluble tumor necrosis factor receptors) compared to a high-glycemic American diet.
Both diets led to changes in fasting glucose levels, but only the legume diet showed a favorable trend in reducing inflammation, suggesting that dietary modifications can positively impact insulin resistance and inflammation biomarkers.
Consumption of a legume-enriched, low-glycemic index diet is associated with biomarkers of insulin resistance and inflammation among men at risk for colorectal cancer.Hartman, TJ., Albert, PS., Zhang, Z., et al.[2023]

References

Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans. [2023]
Dry beans inhibit azoxymethane-induced colon carcinogenesis in F344 rats. [2018]
Mechanisms associated with dose-dependent inhibition of rat mammary carcinogenesis by dry bean (Phaseolus vulgaris, L.). [2008]
Consumption of a legume-enriched, low-glycemic index diet is associated with biomarkers of insulin resistance and inflammation among men at risk for colorectal cancer. [2023]
5.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Feasibility of Increased Navy Bean Powder Consumption for Primary and Secondary Colorectal Cancer Prevention. [2021]
Food Behaviors, Health, and Bean Nutrition Awareness among Low-Income Men: A Pilot Study. [2022]
[Chemical composition and evaluation of the protein quality of beans in adult humans by the short-term nitrogen balance method]. [2018]
The Nutrient and Metabolite Profile of 3 Complementary Legume Foods with Potential to Improve Gut Health in Rural Malawian Children. [2021]
Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. [2023]
Evaluation of Food Intake Biomarkers for Red Bell Peppers in Human Urine Based on HPLC-MS/MS Analysis. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Dietary biomarkers-an update on their validity and applicability in epidemiological studies. [2023]
Adherence to the Mediterranean diet assessed by a novel dietary biomarker score and mortality in older adults: the InCHIANTI cohort study. [2022]